| IND | Investigational new drug |
| HD | Hodgkin’s disease |
| NHL | Non-Hodgkin’s lymphoma |
| MRI | Magnetic resonance imaging |
| SPECT | Single-photon emission computed tomography |
| PET | Positron emission tomography |
| DWI | Diffusion-weighted imaging |
| FDG | Fluorodeoxyglucose |
| NIR | Near-infrared |
| BLI | Bioluminescence imaging |
| HTS | High-throughput screening |
| ATLL | Adult T-cell lymphoma/leukemia |
| HTLV-1 | Human T-cell lymphotropic virus type 1 |
| mAb | Monoclonal antibody |
| ALL | Acute lymphoblastic leukemia |
| R-CHOP | Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.